Blog | Mar 30, 2023

Building a Life Sciences Pipeline: Access to Capital

The past several years culminated into one of the most secure and vigorous periods for capital investment access, and Colorado life sciences companies were able to take full advantage. The Colorado life sciences industry has consistently raised more than a billion investment dollars annually for the past six years, topping $2 billion in 2021. (CBSA) From state grants to larger venture investments, the Colorado healthcare innovation ecosystem has been well-funded and poised for breakthroughs, and Fitzsimons Innovation Community is proud to be the home of many members of that ecosystem.

News | Mar 30, 2023

OncoVerity, Inc. Announces Exclusive Worldwide Licensing Rights to Cusatuzumab and Appoints Max Colao as Chief Executive Officer

Blog | Mar 02, 2023

Building a Life Sciences Pipeline: Cell and Gene Therapy Momentum

Ideas become cures when academia and industry connect. When you talk to Terry Fry, M.D., about why the Gates Institute is one of the best locations in the country to work in cellular and gene therapy, he has a lot of insight. As the executive director of the Gates Institute, a pediatric oncologist, and a pioneer in the development of chimeric antigen receptor (CAR)-T cell therapies, Dr. Fry has an intimate understanding of what it takes to get a drug from initial research phases to commercial manufacturing. And often what it takes is the right facilities with the right partners working together at each stage of development.